Mesna for the Treatment of Hyperhomocysteinemia in Hemodialysis Patients

Publisher： Karger

E-ISSN： 1421-9735|27|3|306-310

ISSN： 0253-5068

Source： Blood Purification, Vol.27, Iss.3, 2009-03, pp. : 306-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methylenetetrahydrofolate Reductase Gene Polymorphism, Hyperhomocysteinemia, and Cardiovascular Diseases in Chronic Hemodialysis Patients

By  

Nephron, Vol. 90, Iss. 1, 2001-12 ,pp. : 43-50

Karger

Access to resources Recommend Favorite

The Common Mutations C677T and A1298C in the Human Methylenetetrahydrofolate Reductase Gene Are Associated with Hyperhomocysteinemia and Cardiovascular Disease in Hemodialysis Patients

By  

Nephron, Vol. 92, Iss. 1, 2002-08 ,pp. : 120-126

Karger

Access to resources Recommend Favorite

Bone Mineral Density in Patients Beginning Hemodialysis Treatment

By  

American Journal of Nephrology, Vol. 22, Iss. 1, 2002-03 ,pp. : 14-17

Karger

Access to resources Recommend Favorite

Diagnosis and Treatment of Tuberculosis in Hemodialysis and Renal Transplant Patients

By  

American Journal of Nephrology, Vol. 20, Iss. 4, 2000-09 ,pp. : 273-277

Karger

Access to resources Recommend Favorite

Sertraline Hydrochloride Treatment for Patients with Hemodialysis Hypotension

By  

Blood Purification, Vol. 20, Iss. 2, 2002-01 ,pp. : 150-153

Karger

Access to resources Recommend Favorite